deltatrials
Completed PHASE4 INTERVENTIONAL 2-arm NCT02217878

Influence of Morphine on Pharmacokinetics and Pharmacodynamics of Ticagrelor in Patients With Acute Myocardial Infarction (IMPRESSION)

A Randomized, Double-blind Study Evaluating the Influence of Morphine on Pharmacokinetics and Pharmacodynamics of Ticagrelor and Its Active Metabolite (AR-C124910XX) in Patients With ST-segment Elevation Myocardial Infarction and Non-ST-segment Elevation Myocardial Infarction.

Sponsor: Collegium Medicum w Bydgoszczy

Conditions Non-ST-segment Elevation Myocardial Infarction ST-segment Elevation Myocardial Infarction VA Drug Interactions
Interventions Morphine Placebo Ticagrelor
Updated 6 times since 2017 Last updated: Aug 12, 2017 Started: Aug 31, 2014 Primary completion: Jun 30, 2015 Completion: Jun 30, 2015
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02217878, this PHASE4 trial focuses on Non-ST-segment Elevation Myocardial Infarction and ST-segment Elevation Myocardial Infarction and remains completed. Sponsored by Collegium Medicum w Bydgoszczy, it has been updated 6 times since 2014, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

~Jan 2017 – ~May 2017 · 4 months · monthly snapshotCompleted~May 2017 – ~Jun 2018 · 13 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE4

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE4

  5. May 2017 — Jun 2018 [monthly]

    Completed PHASE4

▶ Show 1 earlier version

  1. Jan 2017 — May 2017 [monthly]

    Completed PHASE4

    First recorded

Aug 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Collegium Medicum w Bydgoszczy
Data source: Collegium Medicum w Bydgoszczy

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations